Aurelie Garant, M.D.
Assistant Professor

Medical School

Université Laval, Canada (2012)

Residency

McGill University Health Centre (2017), Radiation Oncology

Fellowship

Mayo Clinic (2018), Advanced Radiation Oncology

Featured Publications

A comparison of grade 4 lymphopenia with proton versus photon radiotherapy for esophageal cancer. Advances in radiation oncology

Routman DM, Garant A, Lester SC, Cristobal CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW 2019 4 1 63-69

What Is the Optimal Radiation Technique for Esophageal Cancer? A Dosimetric Comparison of Four Techniques.

Fawaz ZS, Kazandjian S, Tsui JM, Devic DS, Lecavalier-Barsoum M, Vuong T, Elakshar S, Garant A, Lavoie I, Niazi TM Cureus 2018 Jul 10 7 e2985

Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?

Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T Int J Colorectal Dis 2018 Jun 33 6 727-733

Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review.

Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, Vuong T Crit. Rev. Oncol. Hematol. 2017 Dec 120 86-92

Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.

Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N Clin Lung Cancer 2017 09 18 5 565-571

A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.

Siddiqui MRS, Simillis C, Hunter C, Chand M, Bhoday J, Garant A, Vuong T, Artho G, Rasheed S, Tekkis P, Abulafi AM, Brown G Br. J. Cancer 2017 Jun 116 12 1513-1519

Whole Abdominal-Pelvic Radiotherapy in the Management of Primary Ewing Sarcoma of the Peritoneal Cavity.

Barbosa Neto O, Garant A, Shakir S, Brossard J, Garde-Granger P, Freeman C Cureus 2016 Jan 8 1 e455

Intensity-modulated radiation therapy for patients with rectal cancer.

Vuong T, Garant A Colorectal Cancer 2014 3 4 235-238

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

Paliga A, Onerheim R, Gologan A, Chong G, Spatz A, Niazi T, Garant A, Macheto D, Alcindor T, Vuong T Br. J. Cancer 2012 Nov 107 11 1864-8

Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.

Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, Abulafi M, Brown G Ann. Surg. Oncol. 2012 Apr 19 4 1199-205

• American Board of Radiology: Radiobiology/Physics, Clinical Written and Oral Examinations (DABR) (2016-2018)